{"title": "NATURAL KILLER CELL-MEDIATED ADCC in SARS-CoV-2 INFECTION and VACCINATION", "author": "Hagemann; K; Jung; J; Hildebrandt; H; Menzel; S; Bunders; M; F; Peine; Zur Wiesch; Brehm; T T; Addo; L\u00fctgehetmann; Altfeld", "url": null, "hostname": null, "description": null, "sitename": "Topics in Antiviral Medicine", "date": "2019-01-01", "cleaned_text": "NATURAL KILLER CELL-MEDIATED ADCC in SARS-CoV-2 INFECTION and VACCINATION Topics in Antiviral ; 30(1 2022. caused by has emerged as global [pandemic]. While [immune responses]of the adaptive [immune system]have been in focus of [research], the [role]of Natural killer (NK) [cells]in COVID-19 by cells]in response to S1 and NC (p < 0.0001), while [serum]samples from [SARS-CoV-2]-negative individuals did not. Furthermore, [serum]samples from individuals that received the [BNT162b2] [vaccine]induced strong CD107a expression by [NK cells]that increased with the second [vaccination]and was significantly higher than observed in infected individuals (p < 0.0001). As expected, [vaccine]-induced responses were directed against S1 and not against NC [protein]. S1-specific 10-6). Interestingly, [screening]of [serum]samples collected prior to the COVID-19 pandemic identified two individuals with cross-reactive [antibodies]against [SARS-CoV-2]S1, which also induced degranulation demonstrate that [antibodies]induced by anti-SARS-CoV-2 vaccines can trigger significant cell]-mediated "}